Self-renewal capacity of human epidermal Langerhans cells: observations made on a composite tissue allograft

被引:74
作者
Kanitakis, Jean [1 ,2 ]
Morelon, Emmanuel [3 ]
Petruzzo, Palmina [4 ]
Badet, Lionel [4 ]
Dubernard, Jean-Michel [4 ]
机构
[1] Univ Lyon 1, Dept Dermatol Pav R, Ed Herriot Hosp, F-69437 Lyon 03, France
[2] Univ Lyon 1, Dermatopathol Lab, Ed Herriot Hosp, F-69437 Lyon 03, France
[3] Univ Lyon 1, Dept Transplantat Immunol Pav P, Ed Herriot Hosp, F-69437 Lyon 03, France
[4] Ed Herriot Hosp, Dept Transplantat Surg Pav V, Lyon 03, France
关键词
MONOCLONAL-ANTIBODY RITUXIMAB; PEMPHIGUS-VULGARIS ANTIGEN; HUMORAL IMMUNE-RESPONSE; PATHOGENIC AUTOANTIBODIES; KERATINOCYTE ADHESION; GEL; 4-PERCENT; DESMOGLEIN-3; RECEPTORS; DOMAIN; MODEL;
D O I
10.1111/j.1600-0625.2010.01146.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Epidermal Langerhans cells (LC) are dendritic, antigen-presenting cells residing within mammalian epidermis and mucosal epithelia. When massively depleted, they are replaced by cells of bone-marrow origin. However, their renewal within normal skin under steady-state conditions is not precisely known. We observed that epidermal LC within a human hand allograft remain stable in the long term (10 years) and are not replaced by cells of recipient's origin; furthermore, we observed a Langerhans cell in mitosis within the epidermis 8 years postgraft. These results show that under almost physiological conditions, human LC renew in the epidermis by local mitoses of preexisting cells.
引用
收藏
页码:145 / 146
页数:2
相关论文
共 36 条
[1]   ANTIGEN-SPECIFIC IMMUNOADSORPTION OF PATHOGENIC AUTOANTIBODIES IN PEMPHIGUS FOLIACEUS [J].
AMAGAI, M ;
HASHIMOTO, T ;
GREEN, KJ ;
SHIMIZU, N ;
NISHIKAWA, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (06) :895-901
[2]   Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just 'witnesses of disease'? [J].
Amagai, M. ;
Ahmed, A. R. ;
Kitajima, Y. ;
Bystryn, J. C. ;
Milner, Y. ;
Gniadecki, R. ;
Hertl, M. ;
Pincelli, C. ;
Fridkis-Hareli, M. ;
Aoyama, Y. ;
Frusic-Zlotkin, M. ;
Mueller, E. ;
David, M. ;
Mimouni, D. ;
Vind-Kezunovic, D. ;
Michel, B. ;
Mahoney, M. ;
Grando, S. .
EXPERIMENTAL DERMATOLOGY, 2006, 15 (10) :815-831
[3]   AUTOANTIBODIES AGAINST THE AMINO-TERMINAL CADHERIN-LIKE BINDING DOMAIN OF PEMPHIGUS-VULGARIS ANTIGEN ARE PATHOGENIC [J].
AMAGAI, M ;
KARPATI, S ;
PRUSSICK, R ;
KLAUSKOVTUN, V ;
STANLEY, JR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :919-926
[4]   ABSORPTION OF PATHOGENIC AUTOANTIBODIES BY THE EXTRACELLULAR DOMAIN OF PEMPHIGUS-VULGARIS ANTIGEN (DSG3) PRODUCED BY BACULOVIRUS [J].
AMAGAI, M ;
HASHIMOTO, T ;
SHIMIZU, N ;
NISHIKAWA, T .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :59-67
[5]   A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice [J].
Aoki-Ota, M ;
Tsunoda, K ;
Ota, T ;
Iwasaki, T ;
Koyasu, S ;
Amagai, M ;
Nishikawa, T .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (02) :346-354
[6]   Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus [J].
Arin, MJ ;
Engert, A ;
Krieg, T ;
Hunzelmann, N .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) :620-625
[7]   Multiplexed protein array platforms for analysis of autoimmune diseases [J].
Balboni, Imelda ;
Chan, Steven M. ;
Kattah, Michael ;
Tenenbaum, Jessica D. ;
Butte, Atul J. ;
Utz, Paul J. .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :391-418
[8]   Controlling the false discovery rate in behavior genetics research [J].
Benjamini, Y ;
Drai, D ;
Elmer, G ;
Kafkafi, N ;
Golani, I .
BEHAVIOURAL BRAIN RESEARCH, 2001, 125 (1-2) :279-284
[9]   Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms [J].
Berger, F ;
Lau, C ;
Dahlmann, M ;
Ziegler, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (43) :36334-36341
[10]   Paraneoplastic autoimmune multiorgan syndrome: Review of the literature and support for a cytotoxic role in pathogenesis [J].
Billet, Sara E. ;
Grando, Sergei A. ;
Pittelkow, Mark R. .
AUTOIMMUNITY, 2006, 39 (07) :617-630